In subsequent studies, immune suppression by the FAP α+ CAFs was mediated by CXCL12, the chemokine that binds to cancer cells and excludes T cells by a mechanism that depends on signaling by the CXCL12 receptor, CXCR4 [56]. Here, FAP is linked to cancer.